Fri, August 11, 2023

Serge Belanger Reiterated (TRVI) at Strong Buy and Held Target at $8 on, Aug 11th, 2023

Serge Belanger of Needham, Reiterated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $8 on, Aug 11th, 2023.

Serge has made no other calls on TRVI in the last 4 months.



There is 1 other peer that has a rating on TRVI. Out of the 1 peers that are also analyzing TRVI, 0 agree with Serge's Rating of Hold.



This is the rating of the analyst that currently disagrees with Serge


  • Mayank Mamtani of "B. Riley Securities" Initiated at Strong Buy and Held Target at $6 on, Wednesday, April 12th, 2023